[Hepatoprotective and hepatoregenerative effects of di-n-propylacetic molecules].

作者信息

Carraz G, Bernard L

出版信息

Therapie. 1967 May-Jun;22(3):631-9.

PMID:6063441

Abstract

摘要

相似文献

[Hepatoprotective and hepatoregenerative effects of di-n-propylacetic molecules].

Therapie. 1967 May-Jun;22(3):631-9.

[Hepatoprotective drugs in the treatment of acute and chronic liver diseases (author's transl)].

Cesk Gastroenterol Vyz. 1982 Jun;36(3-4):217-23.

[Anticonvulsive action of di-n-propylacetic acid monoureide and of hydantoin derivatives of this acid].

Therapie. 1967 May-Jun;22(3):641-52.

Hepatoprotective potential of Aloe barbadensis Mill. against carbon tetrachloride induced hepatotoxicity.

J Ethnopharmacol. 2007 May 22;111(3):560-6. doi: 10.1016/j.jep.2007.01.008. Epub 2007 Jan 14.

[Prostanoids in treatment of liver diseases].

Wiad Lek. 1998;51(3-4):179-85.

[Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].

Minerva Med. 1982 Oct 20;73(40):2853-60.

NF-kappaB signaling, liver disease and hepatoprotective agents.

Oncogene. 2008 Oct 20;27(48):6228-44. doi: 10.1038/onc.2008.300.

Hepatoprotective activity of Woodfordia fruticosa Kurz flowers against carbon tetrachloride induced hepatotoxicity.

J Ethnopharmacol. 2008 Sep 26;119(2):218-24. doi: 10.1016/j.jep.2008.06.020. Epub 2008 Jun 28.

[Use of heptral in chronic liver diseases].

Eksp Klin Gastroenterol. 2002(6):52-4, 113.

Progress in drug therapy for liver diseases.

Jpn J Pharmacol. 1980;30(Suppl):14P-17P.

引用本文的文献

Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Drugs. 1977 Feb;13(2):81-123. doi: 10.2165/00003495-197713020-00001.

Disposition of valproic acid in patients with liver disease.

Eur J Clin Pharmacol. 1978 Mar 17;13(1):55-60. doi: 10.1007/BF00606683.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验